Log In
BCIQ
Print this Print this
 

Pyroglutamate-3 beta amyloid mAb

  Manage Alerts
Collapse Summary General Information
Company Probiodrug AG
DescriptionIgG 2A isoform of a pyroglutamate-3 beta amyloid mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today